Clinical trial
Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients
NCT00428064 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00428064 |
|---|---|
| Title | Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients |
| Official title | A Randomized, Open-Label Study of Continuous Therapy With Cyclosporine and Sirolimus Versus Induction With Cyclosporine and Sirolimus Followed by Continuous Therapy With Sirolimus in Renal Allograft Recipients |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Renal Transplantation |
| Intervention type | Drug |
| Interventions | Sirolimus, cyclosporine |
| Enrollment | 408 |
| Start date | May 1, 1998 |
| Completion | Jun 1, 2004 |
| First posted | Jan 29, 2007 |
| Last update posted | Jan 29, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: